Recognized by industry leaders for extensive coverage on African Asset Management
Àrgentil invests in Sygen
This product is currently unavailable.
Description
324
Àrgentil Capital Management has announced an undisclosed equity investment in Sygen Pharmaceuticals, an indigenous pharmaceutical company in Nigeria.
